CVRX
CVRx, Inc.$3.04+0.01 (+0.35%)Prev Close$3.00·MCap$77.8M·P/E—·Vol293.2K·Yield—
▲
Buys (12M)
4
$677.2K
▼
Sells (12M)
3
$237.4K
◆
Net Activity
Net Buyer
$439.8K
●
Active Insiders
5
last 12 mo
Over the past 12 months, insider activity at CVRx, Inc. (CVRX) has been dominated by buying, with 4 insider purchases totaling $677.2K and 3 insider sales totaling $237.4K. The most recent insider transaction was by Binkowski Brent (officer: CHIEF OPERATING OFFICER), who purchased $76.4K worth of shares on Aug 13, 2026. CVRx, Inc. operates in the Healthcare sector, within the Medical - Devices industry, with a market cap of $77.8M.
CVRX Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | Binkowski Brent | officer: CHIEF OPERATING OFFICER | Buy | 26,223 | $2.91 | $76.4K | 56,514+87% |
| Aug 13, 2026 | Binkowski Brent | officer: CHIEF OPERATING OFFICER | Sell | 1,309 | $2.55 | $3.3K | 30,291 |
| Mar 16, 2026 | Adamson Philip B. | officer: Chief Medical Officer | Sell | 1,262 | $7.90 | $10.0K | 61,578 |
| Feb 23, 2026 | Jain Mudit K. | director | Buy | 46,800 | $6.36 | $297.6K | 980,183 |
| Feb 20, 2026 | Jain Mudit K. | Director | Buy | 46,800 | $6.36 | $297.6K | 0 |
| Feb 18, 2026 | Jain Mudit K. | Director | Buy | 1,200 | $4.64 | $5.6K | 5,650+27% |
| Jan 8, 2026 | JOHNSON & JOHNSON | 10 percent owner | Sell | 22,337 | $10.03 | $224.0K | 4,031,198 |
| May 15, 2025 | Nielsen Kirk G. | Director | Buy | 10,966 | $5.45 | $59.8K | 0 |
| May 12, 2025 | Hykes Kevin | PRES & CEO | Buy | 5,000 | $4.84 | $24.2K | 0 |
| May 12, 2025 | Jain Mudit K. | Director | Buy | 1,650 | $4.71 | $7.8K | 0 |
| May 12, 2025 | Nielsen Kirk G. | Director | Buy | 187,813 | $5.20 | $977.3K0.7% OS | 0 |
| Nov 19, 2024 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Sell | 1,430 | $13.58 | $19.4K | 0 |
| Aug 15, 2024 | SLATTERY JOSEPH P | Director | Buy | 3,000 | $8.10 | $24.3K | 0 |
| Aug 8, 2024 | SLATTERY JOSEPH P | Director | Buy | 3,000 | $8.24 | $24.7K | 0 |
| Aug 6, 2024 | SLATTERY JOSEPH P | Director | Buy | 2,500 | $9.09 | $22.7K | 0 |
| Aug 5, 2024 | Hykes Kevin | PRES & CEO | Buy | 30,000 | $8.36 | $250.8K | 0 |
| Feb 20, 2024 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Sell | 2,545 | $21.91 | $55.7K | 0 |
| Feb 16, 2024 | JOHNSON & JOHNSON | 10% Owner | Sell | 611,450 | $0.31 | $192.2K2.3% OS | 0 |
| Aug 3, 2023 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Sell | 628 | $18.55 | $11.7K | 0 |
| Jul 31, 2023 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Sell | 1,122 | $17.49 | $19.6K | 0 |
| Nov 28, 2022 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Sell | 4,600 | $11.94 | $54.9K | 0 |
| May 24, 2022 | Nielsen Kirk G. | Director | Buy | 8,070 | $5.05 | $40.8K | 0 |
| May 19, 2022 | Nielsen Kirk G. | Director | Buy | 28,795 | $5.04 | $145.0K | 0 |
| May 3, 2022 | Nielsen Kirk G. | Director | Buy | 62,304 | $5.99 | $373.5K | 0 |
| Apr 28, 2022 | Nielsen Kirk G. | Director | Buy | 42,088 | $5.97 | $251.3K | 0 |
| Feb 28, 2022 | Jain Mudit K. | Director | Buy | 600 | $9.03 | $5.4K | 0 |
| Feb 24, 2022 | Nielsen Kirk G. | Director | Buy | 3,400 | $8.24 | $28.0K | 0 |
| Feb 18, 2022 | Nielsen Kirk G. | Director | Buy | 104,867 | $7.97 | $836.0K | 0 |
| Nov 18, 2021 | Jain Mudit K. | Director | Buy | 1,175 | $14.39 | $16.9K | 0 |
| Aug 12, 2021 | Jain Mudit K. | Director | Buy | 625 | $19.72 | $12.3K | 0 |
| Jul 2, 2021 | GLAXOSMITHKLINE PLC | 10% Owner | Buy | 275,000 | $18.00 | $4.95M1.0% OS | 0 |
| Jul 2, 2021 | NEW ENTERPRISE ASSOCIATES 10 L P | 10% Owner | Buy | 225,500 | $18.00 | $4.06M0.9% OS | 0 |
| Jul 1, 2021 | Jain Mudit K. | Director | Buy | 223,222 | $18.03 | $4.03M0.8% OS | 0 |
| Jun 30, 2021 | NEHRA JOHN M | Director | Buy | 27,877 | $18.03 | $502.6K | 0 |
CVRX Insider Buying Activity
The following table shows recent insider purchases of CVRx, Inc. (CVRX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | Binkowski Brent | officer: CHIEF OPERATING OFFICER | Buy | 26,223 | $2.91 | $76.4K | 56,514+87% |
| Feb 23, 2026 | Jain Mudit K. | director | Buy | 46,800 | $6.36 | $297.6K | 980,183 |
| Feb 20, 2026 | Jain Mudit K. | Director | Buy | 46,800 | $6.36 | $297.6K | 0 |
| Feb 18, 2026 | Jain Mudit K. | Director | Buy | 1,200 | $4.64 | $5.6K | 5,650+27% |
| May 15, 2025 | Nielsen Kirk G. | Director | Buy | 10,966 | $5.45 | $59.8K | 0 |
| May 12, 2025 | Hykes Kevin | PRES & CEO | Buy | 5,000 | $4.84 | $24.2K | 0 |
| May 12, 2025 | Jain Mudit K. | Director | Buy | 1,650 | $4.71 | $7.8K | 0 |
| May 12, 2025 | Nielsen Kirk G. | Director | Buy | 187,813 | $5.20 | $977.3K0.7% OS | 0 |
| Aug 15, 2024 | SLATTERY JOSEPH P | Director | Buy | 3,000 | $8.10 | $24.3K | 0 |
| Aug 8, 2024 | SLATTERY JOSEPH P | Director | Buy | 3,000 | $8.24 | $24.7K | 0 |
| Aug 6, 2024 | SLATTERY JOSEPH P | Director | Buy | 2,500 | $9.09 | $22.7K | 0 |
| Aug 5, 2024 | Hykes Kevin | PRES & CEO | Buy | 30,000 | $8.36 | $250.8K | 0 |
| May 24, 2022 | Nielsen Kirk G. | Director | Buy | 8,070 | $5.05 | $40.8K | 0 |
| May 19, 2022 | Nielsen Kirk G. | Director | Buy | 28,795 | $5.04 | $145.0K | 0 |
| May 3, 2022 | Nielsen Kirk G. | Director | Buy | 62,304 | $5.99 | $373.5K | 0 |
| Apr 28, 2022 | Nielsen Kirk G. | Director | Buy | 42,088 | $5.97 | $251.3K | 0 |
| Feb 28, 2022 | Jain Mudit K. | Director | Buy | 600 | $9.03 | $5.4K | 0 |
| Feb 24, 2022 | Nielsen Kirk G. | Director | Buy | 3,400 | $8.24 | $28.0K | 0 |
| Feb 18, 2022 | Nielsen Kirk G. | Director | Buy | 104,867 | $7.97 | $836.0K | 0 |
| Nov 18, 2021 | Jain Mudit K. | Director | Buy | 1,175 | $14.39 | $16.9K | 0 |
| Aug 12, 2021 | Jain Mudit K. | Director | Buy | 625 | $19.72 | $12.3K | 0 |
| Jul 2, 2021 | GLAXOSMITHKLINE PLC | 10% Owner | Buy | 275,000 | $18.00 | $4.95M1.0% OS | 0 |
| Jul 2, 2021 | NEW ENTERPRISE ASSOCIATES 10 L P | 10% Owner | Buy | 225,500 | $18.00 | $4.06M0.9% OS | 0 |
| Jul 1, 2021 | Jain Mudit K. | Director | Buy | 223,222 | $18.03 | $4.03M0.8% OS | 0 |
| Jun 30, 2021 | NEHRA JOHN M | Director | Buy | 27,877 | $18.03 | $502.6K | 0 |
CVRX Insider Selling Activity
The following table shows recent insider sales of CVRx, Inc. (CVRX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | Binkowski Brent | officer: CHIEF OPERATING OFFICER | Sell | 1,309 | $2.55 | $3.3K | 30,291 |
| Mar 16, 2026 | Adamson Philip B. | officer: Chief Medical Officer | Sell | 1,262 | $7.90 | $10.0K | 61,578 |
| Jan 8, 2026 | JOHNSON & JOHNSON | 10 percent owner | Sell | 22,337 | $10.03 | $224.0K | 4,031,198 |
| Nov 19, 2024 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Sell | 1,430 | $13.58 | $19.4K | 0 |
| Feb 20, 2024 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Sell | 2,545 | $21.91 | $55.7K | 0 |
| Feb 16, 2024 | JOHNSON & JOHNSON | 10% Owner | Sell | 611,450 | $0.31 | $192.2K2.3% OS | 0 |
| Aug 3, 2023 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Sell | 628 | $18.55 | $11.7K | 0 |
| Jul 31, 2023 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Sell | 1,122 | $17.49 | $19.6K | 0 |
| Nov 28, 2022 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Sell | 4,600 | $11.94 | $54.9K | 0 |
CVRX Insiders
Similar Stocks to CVRX
SYK
Stryker Corporation
$281.11-0.32%
$105.57B
BSX
Boston Scientific Corporation
$43.93-2.48%
$66.83B
EW
Edwards Lifesciences Corporation
$85.82+0.33%
$49.62B
DXCM
DexCom, Inc.
$86.69+2.37%
$31.33B
ZBH
Zimmer Biomet Holdings, Inc.
$99.10+2.61%
$18.09B
GMED
Globus Medical, Inc.
$74.78-1.29%
$10.01B
GKOS
Glaukos Corporation
$172.13+0.61%
$9.87B
PODD
Insulet Corp.
$139.63+1.32%
$9.14B